CinCor Pharma

$32.00 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About CinCor Pharma

CinCor Pharma Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is engaged in developing medications targeting cardiovascular, metabolic and kidney diseases. Its lead CIN-107, is an aldosterone synthase inhibitor for treatment resistant of hypertension and primary aldosteronism. CIN-107 works through the renin-angiotensin-aldosterone system (RAAS), which is responsible for regulating the body's fluid and electrolyte balance.

Stock Analysis

last close $32.93
1-mo return 63%
3-mo return 56.6%
avg daily vol. 276.95T
52-week high 43.15
52-week low 13
market cap. $884M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. 90.8%
baraka

Subscribe now for daily local and international financial news

Subscribe